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Background: Uganda has one of the highest total fertility rates globally and in Sub-Saharan Africa. Her high fertility
is mainly attributed to the high unmet need for family planning. Use of Long-acting reversible contraceptives
(LARC) is low (13%) in Uganda yet they are the most cost-effective contraceptives. This study aimed to assess the
reproductive aged women’s knowledge, attitudes, and factors associated with use of LARC.
Methods: A cross-sectional study was conducted involving 565 women (15–49 years) attending private and public
health facilities in Lubaga division, Kampala district. Semi-structured questionnaires were used to measure
knowledge, attitudes and factors associated with use of LARC; Intra-Uterine Devices, Implants and Injectables. The
outcome variable was current use of LARC. A generalized linear regression model was run in STATA version12.0.
Prevalence Risk Ratios for associations between current LARC use and independent factors were obtained and
regarded significant at 95% CI with p < 0.05.
Results: Mean age (SD) and current use of LARC was 26.34 (5.35) and 31.7% respectively. Factors associated with
current use of LARC were; previous use adj.PRR 2.89; (95% CI 2.29, 3.81), knowledge of implant administration site
adj.PRR 1.83; (95% CI 1.17, 2.87), and perception that; male partner decisions positively influence their contraceptive
choices adj.PRR 1.49; (95% CI 1.18, 1.88). Contrary, perception that LARC should be used by married women was
negatively associated with use of LARC adj.PRR 0.63; (95% CI 0.44, 0.90).
Conclusion: Knowledge about site of administration, previous use of LARC and women’s attitude that male
partners’ choice influence their contraceptive decisions were positively associated with current use of LARC.
Contrary, the attitude that LARC was for married women was negatively associated with its use. This study suggests
a need to strengthen client education about LARC to dispel possible myths and to consider integrating male
partner’s decision making in contraceptive choices for women.
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Uganda’s total fertility rate (TFR) at 6.2 is one of the high-
est in sub-Saharan Africa and globally [1]. Uganda more
so, has a high maternal mortality ratio (MMR) at 435 ma-
ternal deaths per 100,000 live births and an infant mortal-
ity rate (IMR) of 54 per 1,000 live births per year [2]. High
maternal morbidity and mortality could partly be attrib-
uted to unintended pregnancies, short birth intervals and
higher risk of obstetric and newborn complications associ-
ated with low contraceptive use [3]. About 44% of preg-
nancies in Uganda are unintended [2] with occurrence of
unsafe abortions estimated at 62 per 1,000 women aged
15–49 years [4]. These undesirable maternal and child
health outcomes associated with high TFR could be sub-
stantially reduced by meeting the family planning (FP)
needs of women in developing countries [5]. Provision of
highly efficacious family planning (FP) services contributes
to a reduction in maternal mortality by lowering the risk
of maternal death per birth hence preventing high-risk
and high-parity births [6]. It also offers individuals and
couples’ ability to anticipate and attain the desired number
of children by birth spacing and timing [7].
Use of long acting reversible methods is proposed as a
strategy to reverse undesirable maternal health conse-
quences in developing countries [8,9]. Scientific evidence
has determined implant and copper-bearing Intra-Uterine
Device (IUD) contraceptives to be highly effective and well
tolerated [10,11]. Similarly, injectables and implants are
proven to be safe, effective and reversible contraceptive
options [12,13]. Despite evidence of LARC effectiveness
and safety, actual uptake in resource-poor settings like
Uganda is low, and is possibly affected by several factors
such as knowledge and general awareness of contraceptive
methods [14], access to different contraceptive methods,
user characteristics, technology [15] and socio-economic
status [16].
Currently in Uganda, the contraceptive prevalence rate
(CPR) is 30% and LARC prevalence is as low as 13%
among all women [2,17]. The prevalence of IUD use is
lowest at 0.4%, implants as low as 1.9% and injectable
contraceptives at 10.7% [2]. Kampala district, the study
site, has a LARC prevalence of 22.7% with implant (1.6%),
IUD (1.8%) and injectables (19.3%) [2]. This study set out
to determine the reasons for low use of LARC in Lubaga
division, Kampala, particularly assess knowledge and atti-
tudes among women of reproductive age use of LARC at-
tending reproductive health services.
Methods
A health facility-based, cross-sectional study was con-
ducted for a period of nine weeks between March and
April 2012 in Lubaga division. Lubaga is one of five ad-
ministrative divisions in Kampala district, the capital of
Uganda. The total population of the area is 411,900 with53.6% females [18] and about 92% lives in peri-urban
locations [19]. Lubaga division’s health structure is cur-
rently comprised of 124 registered health facilities and
these are in three categories; 2 Public facilities, 120
private for profit and 2 Private Not-For-Profit (PNFP)
which all provided reproductive health services including
LARC services. The participants were both FP users and
non-users who were females 15–49 years attending any
reproductive health service (i.e. family planning, post-
natal and outpatient clinics) in Lubaga division. A family
planning user was defined as a woman who at the time
of the interview was currently using any contraceptive
method [2]. A non-FP user was defined as a woman who
at the time of the interview had never used any contra-
ceptive or had previously used a contraceptive but dis-
continued its use.
Data was entered, cleaned using Epi info 3.5.1 and
statistical analysis done with STATA Version12.0. Data
was collected using semi-structured interviewer admin-
istered questionnaires which contained information on
independent variables. During administration of inter-
views, the respondents were not prompted with any
contraceptive pictorials or FP product names. The out-
come variable was binary i.e. current user or non-user
of LARC methods. Prior to data collection, question-
naires were pre-tested at a non-participating health
centre III in Nakawa division in Kampala that was
purposively selected due to similarity of participants’
socio-cultural characteristics in order to determine their
suitability for collecting study data and then editing of
the data collection tools appropriately. Field editing of
questionnaires was conducted by the supervisors on
daily basis to check for completeness.
Sample size
The modified Kish, Leslie formula (1965) was used to es-
timate the sample size [20]. A total of 565 was computed
using a 95% confidence interval, 3.5% precision, 20.5%
prevalence for current use of LARC in Kampala district
[21] and 9% of the sample size used to compensate for
non-response [22]. Using probability proportionate-to-
size of daily FP clinic attendance by category of health
facility, 20 health facilities were selected. Among the
total of 20 health facilities selected, 16 private clinics
were randomly selected and 2 PNFP’s and 2 Public
health facilities were purposively selected respectively.
Probability proportionate-to-size sampling was used to
select the number of participants to be recruited from
each health facility. At each health facility, the first re-
spondent from each clinic (FP, PNC and outpatient
clinics) was selected randomly. The subsequent respon-
dents were selected systematically from the daily clinic
attendance list until the required respondents were
selected.
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The data was collected using a semi-structured ques-
tionnaire developed, piloted and translated into the
predominant local language (Luganda) by the research
team. Information on participants’ socio-demographic
characteristics, LARC knowledge attitudes towards use
of LARC was collected.
Knowledge of LARC
Participants’ knowledge was measured by the number of
correct responses to 6 unprompted questions. The first
three unprompted questions asked were on knowledge
about duration of effective protection from pregnancy of
IUD, implant and injectable contraceptives. The next
three unprompted questions were on knowledge of the
site of administration of IUD, implant and injectable con-
traceptives. A binary response to each question of yes or
no was elicited.
Attitudes towards LARC
The items on attitude of participants towards use of LARC
were scored using a 5-point likert scale with 5 responses.
The responses were categorized as; ‘strongly agree’, ‘agree’,
‘not sure’, disagree’ and ‘strongly disagree’. These 5 re-
sponses where then collapsed into binary variables; agree
and disagree. ‘Agree’ for those who responded ‘agree’ or
‘strongly agree’ and ‘disagree’ for those who responded
‘disagree’, ‘strongly disagree’ or ‘not sure’. This measure-
ment is similar to a study in North Ethiopia which mea-
sured knowledge and attitudes towards long-acting and
Permanent (LAPM) contraceptives [23].
Statistical analysis
Double data entry and cleaning was done in Epi info
3.5.1 which was then exported to STATA version 12.0 in
order to conduct statistical analyses. Descriptive analysis
for summary statistics was conducted for the independ-
ent variables. The outcome variable was current use of
LARC methods which was a binary categorical variable
(yes, no). The study computed a prevalence 31.7% for
the outcome variable, which is considered to be high
therefore Prevalence Risk Ratios (PRR) were used as the
appropriate measure of association [24,25]. The PRR
was computed for associations between current use of
LARC and independent variables using Generalized
Linear Model analysis with robust standard errors. Un-
adjusted PRR were computed with their corresponding
95% confidence intervals (95% CI). The independent
variables with a p ≤ 0.10 [26] and biologically plausible fac-
tors were included in the multivariable model for multi-
variable analysis in order to identify their independent
predictors of use of LARC. Independent variables identi-
fied as statistically significant in the multivariable modelwere reported as being independently associated with
current use of LARC.
Ethics
Ethical approval to conduct this study was obtained
from the Makerere University School of Public Health
(MakSPH) Higher Degree Research and Ethics Commit-
tee on the 22nd February 2012. Informed consent was
obtained from all respondents above 18 years in both
verbal and written forms. For study participants who
were between 15 to 18 years of age, consent and assent
was obtained from their parents/guardians and the re-
spondents respectively. Privacy and confidentiality of re-
spondent information was upheld by the research team.
Respondent anonymity was observed through use of ques-
tionnaire identification numbers. Permission to carry out
this study in Lubaga division was obtained from Lubaga
division urban council.
Results
The Table 1 shows the baseline characteristics of women
aged 15 to 49 years in the study. A total of 565 partici-
pants were interviewed from twenty health facilities in
Lubaga division, Kampala district. The mean age of the
respondents was 26.3 years (SD: 5.34). All 565 respon-
dents that were sampled were eligible for the interview.
Among the respondents, 72.6% were married, 46.5% had
attended secondary education and 39.3% were Catholics.
More than half (56.6%) had delivered between 1 to 3 chil-
dren in their lifetime.
The proportion of participants currently using LARC
methods was 31.7%. Among 565 study participants,
about 21% (120 out of 565) reported having ever had an
abortion. About 57% (325 of 565) reported having used
at least one LARC method prior to current use of LARC
at the time of the interview.
Among all study respondents, knowledge of duration
of effectiveness of specific LARC methods was generally
higher among those currently using LARC methods
(Table 2). Among all the study participants, knowledge
of effective duration of effectiveness of IUD, implant and
injectable contraceptives was 68.5%, 69.9% and 87.4%
respectively.
Knowledge of administration site for IUD, implant and
injectables was 75.9%, 80.2% and 91.9% respectively.
Knowledge levels of administration site of specific LARC
methods were high among current use of LARC i.e.
82.7%, 88.3% and 95.5% for IUD, implant and injectables
respectively (Table 2).
In Table 3, nearly all participants 95% (534 out of 565)
agreed that LARC methods can effectively prevent the
occurrence of pregnancy. Out of the 565 participants,
513 (90.8%) agreed that health workers should explain
the contraceptive side effects to them. About one third
Table 1 Characteristics of reproductive aged
(15 – 49 years) female respondents in Lubaga division,
Mar-Apr 2012
Variable Frequency, N=565 Percentage (%)
Age*
15 – 19 34 6.0
20 – 24 194 34.3
25 – 29 211 37.3
30 – 34 78 13.8











Primary/Never attended 119 21.1
Secondary 263 46.5
Tertiary 183 32.4
Number of children delivered
0 139 24.6
1 – 3 320 56.6
4+ 106 18.8
Ever had an abortion
No 445 78.8
Yes 120 21.2
Previous use of LARC
No 230 40.7
Yes 325 59.3
Current use of LARC
No 386 68.3
Yes 179 31.7
*Range = 15 – 49, mean age (SD) = 26.34 ( 5.35), median (IQR) = 25 (23 – 29).
Table 2 Knowledge of LARC among women of
reproductive age in Lubaga division, 2012 (N = 565)
Variable Total population,
N=565
Current use of LARC,
N=179
n (%) n (%)
Knowledge of LARC
a) Knowledge of duration of protection from pregnancy
IUD 387 (68.5) 136 (75.98)
Implant 395 (69.9) 139 (77.65)
Injectable 494 (87.4) 161 (89.94)
b) Knowledge of site of administration
IUD 429 (75.9) 148 (82.68)
Implant 453 (80.2) 158 (88.27)
Injectable 519 (91.9) 171 (95.53)
Table 3 Attitudes towards use of LARC among
respondents in Lubaga division
Items on attitude Agree Disagree
n (%) n (%)
LARC effectively prevents occurrence of
pregnancy
534 (94.5) 31 (5.5)
LARC methods can cause permanent
infertility
186 (32.9) 379 (67.1)
LARC should be used by married women 108 (19.1) 513 (80.9)
Partner should decide your contraceptive
method to use
272 (48.1) 293 (51.9)
Health workers should explain contraceptive
side effects
513 (90.8) 52 (9.2)
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LARC can cause permanent infertility.
Approximately half (48.1%), 272 of 565 respondents
agreed that the contraceptive to use is their partners’
decision.
Table 4 shows bivariate analysis of factors associated
with current use of LARC methods. Current use of LARC
was about one and a half (1.47) times higher among re-
spondents who had children than those who had none
(PRR 1.47; 95% CI 1.03, 2.11; p = 0.036). Also, current use
of LARC about three times significantly higher amongrespondents who previously used LARC than those who
didn’t previously use LARC (PRR 3.05; 95% CI 2.33,
4.00; p = 0.000). Current use of LARC was significantly
increased; approximately 1.46 times higher among re-
spondents with knowledge of duration of protection
from pregnancy by IUD and implants (PRR 1.46; 95% CI
1.10, 2.02; p = 0.006) and (PRR 1.45; 95% CI 1.11, 2.02;
p = 0.009) respectively than those without knowledge.
On the other hand, current use of LARC methods was
significantly reduced if the respondents agreed that LARC
should be used by married women (PRR 0.62; 95% CI
0.43, 0.92; p = 0.016).
After adjusting for confounding at multivariable ana-
lysis (Table 5), factors that remained significantly associ-
ated with current use of LARC were: previous use of
LARC (adj.PRR 2.76; 95% CI 2.10,3.62; p = 0.000), know-
ledge of site of administration of implants (adj.PRR 1.83;
95% CI 1.17,2.87; p = 0.008) and respondents agreeing that
their partners should make decisions for their contracep-
tive to use (adj.PRR 1.49; 95% CI 1.18,1.88; p = 0.000). On
the other hand, factors associated with reduced use of
LARC currently was respondents agreeing that LARC
Table 4 Bivariate analysis of independent variables associated with current use of LARC
OUTCOME: Current use of LARC
Independent variable Total Current use of LARC, n (%) Unadjusted PRR (95% CI) p-value
Age (years)
< 24 228 65 (36.31) 1
≥ 24 337 114 (63.69) 1.19 (0.92-1.53) 0.187
No. of children delivered
None 113 26 (14.53) 1
Has children 426 153 (85.47) 1.47 (1.03-2.11) 0.036*
Religion
Non catholic 343 107 (59.78) 1
Catholic 222 72 (40.2) 1.03 (0.81-1.33) 0.757
Marital status
Never married 113 27 (15.08) 1
Ever married 452 152 (84.92) 1.41 (0.99-2.01) 0.058
Previous use of LARC
No 325 55 (30.73) 1
Yes 230 124 (69.27) 3.05 (2.33-4.00) 0.000***
Occupation
Unemployed 301 105 (58.66) 1
Employed 264 74 (41.34) 0.80 (0.63-1.03) 0.083
Level of education
Never attended 115 40 (22.35) 1
Attended 446 139 (77.65) 0.90 (0.67-1.19) 0.452
Abortion
No 441 137 (76.54) 1
Yes 120 42 (23.46) 0.66 (0.34-1.28) 0.217
Knowledge of duration of protection from pregnancy
IUD
No 178 43 (24.02) 1
Yes 387 136 (75.98) 1.46 (1.10-2.02) 0.006**
Implant
No 170 40 (22.35) 1
Yes 395 139 (77.65) 1.45 (1.11-2.02) 0.009**
Injectable
No 71 18 (10.06) 1
Yes 494 161 (89.94) 1.29 (0.85-1.96) 0.240
Knowledge of site of administration
IUD
No 136 31 (17.32) 1
Yes 429 148 (82.68) 1.51 (1.08-2.12) 0.016*
Implant
No 112 21 (11.73) 1
Yes 453 158 (88.27) 1.86 (1.24-2.79) 0.003**
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Table 4 Bivariate analysis of independent variables associated with current use of LARC (Continued)
Injectable
No 46 8 (4.47) 1
Yes 519 171 (95.53) 1.89 (0.99-3.61) 0.051
Attitudes towards use of LARC
LARC should be used by married women
Disagree 457 156 (87.15) 1
Agree 108 23 (12.85) 0.62 (0.43-0.92) 0.016*
Partner should decide your contraceptive use
Disagree 293 70 (39.11) 1
Agree 272 109 (60.89) 1.68 (1.31-2.16) 0.000***
LARC prevents pregnancy occurrence
Disagree 31 9 (5.03) 1
Agree 534 170 (94.97) 1.09 (0.62-1.93) 0.749
Health workers should explain the contraceptive side effects
Disagree 52 11 (6.15) 1
Agree 513 168 (93.85) 1.79 (1.01-3.17) 0.047*
LARC can cause permanent infertility
Disagree 379 112 (62.57) 1
Agree 186 67 (37.43) 1.22 (0.95-1.56) 0.116
Statistically significant at *p < 0.05, **p < 0.01 ***p < 0.001.
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0.44,0.90; p = 0.000).
Discussion
The aim of this study was to assess the level of knowledge
and attitudes towards LARC methods as well as factors
associated with its use among women of reproductive age
attending reproductive health services in Lubaga, division
Kampala. Whereas the level of knowledge of specific
LARC methods in Lubaga division (Table 2) was slightly
higher than that of Kampala district [2], it is still
sub-optimal. However across the three LARC methods,
women had higher levels of knowledge about injectable
contraceptives than implants and IUDs. Knowledge of
duration of protection from pregnancy was higher for
injectable contraceptives than implant and IUD. Know-
ledge of site of administration for all LARC methods
was also relatively high comparable to the national
knowledge levels for the three LARC methods [2] sug-
gesting that the needed FP information is reaching
the women in Lubaga. The high level of knowledge of
LARC methods in our study may be explained by the
highly selective group of females selected from health
facilities. Lubaga, a peri-urban setting also has a high
number of health units which is likely to increase phys-
ical access to FP services including contraceptive coun-
seling. However, there is need for further research into
why the high level of knowledge does not translate into
actual higher use of LARC in this urban setting [2].Low use of LARC may be due to misconceptions about
causation of permanent infertility (Table 3). A survey in
Ghana, revealed that women had high knowledge levels of
IUD but cited its side effects as the main reason for non-
use [27]. Similarly, studies in Kenya and Nigeria revealed
that among injectable and implanon (implant) users re-
spectively, misconceptions [28], side effects [28,29] and
husbands’ opposition [28] were main reasons for their
discontinuation.
In contrast, a study in Jimma, Ethiopia, revealed that
women were least knowledgeable about IUD and more
knowledgeable about implants and injectables especially
among married couples [30]. The difference in findings
could be explained by the fact that the Ethiopian study
was conducted among married couples which could have
been a highly self-selected group that had jointly agreed to
use LARC.
In a study in rural Ethiopia, knowledge of IUD was
much lower at 13.1% [31] when compared with know-
ledge of IUD in this study in Lubaga division. Though
knowledge of injectable contraceptives (97.8%) is nearly
universal when compared to this study in Lubaga, know-
ledge of implants (74.4%) was comparable [31]. These
study differences in knowledge of IUD and implants could
potentially be due to rural–urban differences in socio-
demographics and availability of specific LARC methods.
Since injectable contraceptives are the predominant LARC
method currently used in both studies, this may suggest
that injectable contraceptives are the LARC method
Table 5 Multivariable analysis of factors associated with current use of LARC
OUTCOME: Current use of LARC
Total Current use of LARC, n (%) Unadjusted (95% CI) PRR Adjusted (95% CI) PRR
Age (years)
< 24 228 65 (36.31) 1 1
≥ 24 337 114 (63.69) 1.19 (0.92-1.53) 1.01 (0.81-1.27)
No. of children delivered
None 113 26 (14.53) 1 1
Has children 426 153 (85.47) 1.47 (1.03-2.11) 1.20 (0.85-1.68)
Marital status
Never married 113 27 (15.08) 1 1
Ever married 452 152 (84.92) 1.41 (0.99-2.01) 1.12 (0.80-1.58)
Previous use of LARC
No 325 55 (30.73) 1 1
Yes 230 124 (69.27) 3.05 (2.33-4.00) 2.89 (2.19-3.81) ***
Knowledge of duration of protection from pregnancy
IUD
No 178 43 (24.02) 1 1
Yes 387 136 (75.98) 1.46 (1.10-2.02) 1.14 (0.79-1.63)
Implant
No 170 40 (22.35) 1 1
Yes 395 139 (77.65) 1.45 (1.11-2.02) 0.88 (0.60-1.28)
Knowledge of site of administration
IUD
No 136 31 (17.32) 1 1
Yes 429 148 (82.68) 1.51 (1.08-2.12) 0.94 (0.65-1.37)
Implant
No 112 21 (11.73) 1 1
Yes 453 158 (88.27) 1.86 (1.24-2.79) 1.83 (1.17-2.87)
LARC should be used by married women
Disagree 457 156 (87.15) 1 1
Agree 108 23 (12.85) 0.62 (0.43-0.92) 0.63 (0.44-0.90) *
Partner should decide your contraceptive to use
Disagree 293 70 (39.11) 1 1
Agree 272 109 (60.89) 1.68 (1.31-2.16) 1.49 (1.18-1.88) ***
Health workers should explain contraceptive side effects
Disagree 52 11 (6.15) 1 1
Agree 513 168 (93.85) 1.79 (1.01-3.17) 1.45 (0.84-2.49)
Statistically significant at *p < 0.05, ***p < 0.001.
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both community and facility levels when compared to fa-
cility provision of implants and IUD in some sub-Saharan
countries like Nigeria [32], Madagascar [33], Ethiopia [34]
and also Uganda [35,36] could have contributed to high
injectable contraceptive knowledge and current use.
Nearly half (48.1%) of the women in this study thought
that their male partners should decide on the contraceptiveto use (Table 3) suggesting that socio-cultural perceptions
play an important part in the contraceptive choices made.
A study in Kenya and Ethiopia found that partner ap-
proval [37] and husband support [38] influences use of
FP services and contraceptives respectively. Our study
in Lubaga had similar findings on partner’s decision on
spouses’ choice of contraceptive. Partner decision was
associated with women’s contraceptive use similar to
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ner approval, partner’s support [39,40] or partner objec-
tions [41-43] towards contraceptive choice influenced
contraceptive use. In South Africa, women that strongly
agreed to male decision making regarding child-bearing
did not influence effective contraception [44]. In Uganda
[45,46] and Burkina Faso [47], scientific evidence has also
shown that positive influence of male partners may affect
maternal and child health outcomes. Nearly half of the
women in this study thought that their male partners
should decide the contraceptive to use therefore socio-
cultural perceptions in Lubaga especially related to roles
of males and females in decision making in families might
explain these attitudes among women.
In Nigeria, [48] and Bangladesh [42], acceptors of long
acting contraception were more likely to be married
women. A study in Nigeria consistent with our study
showed that almost half of the married women had pre-
viously used IUD and injectables [49]. Since comparable
proportions of use of LARC in all three studies were
married women, this may suggest that they may have
good attitudes towards using LARC methods.
The findings of our study should be interpreted in
light of some limitations; the study was cross-sectional
therefore we could not establish temporality between
current use of LARC and the independent factors. Since
the study relied on the respondents’ self-report, there
could have been potential for recall bias about the his-
tory related to use of LARC methods. We attempted to
control for potential confounders of known factors in
the multivariable analysis. Misclassification bias may
have been introduced when collapsing attitude items
from a 5 to 3 point likert scales, the new categorization
assumed that those reporting “unsure” disagreed. How-
ever, given the small number of responses in the “un-
sure” category this is unlikely to have greatly biased the
results. Suggestion for future research could include
conducting qualitative data collection methods in order
to adequately assess behaviors of women associated with
contraceptive use.
Conclusion
This study revealed a relatively low level of current use
of LARC among women attending clinics in Lubaga,
Kampala. Knowledge of site of administration of implants,
previous use, and women’s attitude about the important
role of male partners in their choice of contraceptives
was associated with current use of LARC. Strategies to
strengthen client education may be integrated within re-
productive health programs in Lubaga division in order
to dispel possible myths about LARC. Involving males
in the decision making process of contraceptives may
also be integrated into strategies to promote family
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